About Essenvia
Essenvia is a company based in Los Angeles (United States) founded in 2018 by Soumya Mahapatra and Basant Sahoo. Essenvia has raised $5.53 million across 3 funding rounds from investors including Benhamou Global Ventures, Pasadena Angels and Wavemaker 360. The company has 9 employees as of April 05, 2024. Essenvia offers products and services including eSTAR Interface, RIM Platform, Registrations Management, Submissions Management, and Change Assessment. Essenvia operates in a competitive market with competitors including RIMSYS, ValGenesis, Sware, Virtify and 3Aware, among others.
- Headquarter Los Angeles, United States
- Employees 9 as on 05 Apr, 2024
- Founders Soumya Mahapatra, Basant Sahoo
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Essenvia Solutions Private Limited
- Date of Incorporation 27 Jan, 2021
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$242.93 K (USD)25.69as on Mar 31, 2023
-
Net Profit
$27.31 K (USD)25.11as on Mar 31, 2023
-
EBITDA
$88.09 K (USD)16.04as on Mar 31, 2023
-
Total Equity Funding
$5.53 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
Benhamou Global Ventures
& 5 more
-
Employee Count
9
as on Apr 05, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Essenvia
Essenvia offers a comprehensive portfolio of products and services, including eSTAR Interface, RIM Platform, Registrations Management, Submissions Management, and Change Assessment.
Facilitates collaborative authoring for FDA 510(k) submissions.
Manages workflows and ensures compliance across product lifecycles.
Handles product registration and tracking for global markets.
Automates creation and management of regulatory submissions.
Evaluates regulatory impacts of product changes.
People of Essenvia
Unlock access to complete
Funding Insights of Essenvia
Essenvia has successfully raised a total of $5.53M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Essenvia
Essenvia has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Benhamou Global Ventures, Pasadena Angels and Wavemaker 360.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
A specialized seed fund is operated for enterprise infrastructure startups.
|
Locked | Locked | Locked | |
|
Early-stage venture capital firm focusing on Asia regions.
|
Locked | Locked | Locked |
Investor details for Essenvia
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Essenvia
Investment portfolio details for Essenvia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Essenvia
Detailed financials for Essenvia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Essenvia Comparisons
Peer comparison for Essenvia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Essenvia
Essenvia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RIMSYS, ValGenesis, Sware, Virtify and 3Aware, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medical device regulatory management software is provided for healthcare organizations.
|
|
| Locked | Locked | Locked |
Validation software is provided for life sciences companies.
|
|
| Locked | Locked | Locked |
Validation automation platform for regulated systems is provided.
|
|
| Locked | Locked | Locked |
Delivers content and compliance management software solutions.
|
|
| Locked | Locked | Locked |
Provider of real-world evidence platform for MedTech device safety and performance
|
Detailed competitors of Essenvia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Essenvia
Complete news archive for Essenvia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Essenvia
Essenvia was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Essenvia is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Soumya Mahapatra is the current CEO of Essenvia. They have also founded this company.
Essenvia is a funded company, having raised a total of $5.53M across 3 funding rounds to date.
As of Apr 05, 2024, the latest employee count at Essenvia is 9.
Annual revenue of Essenvia is $242.93K as on Mar 31, 2023.
Essenvia was founded in 2018 in Los Angeles, United States, as a provider of software solutions tailored to medical device companies. Tools are offered for managing pre- and post-market workflows, including dashboards that facilitate cross-functional collaboration, processes for handling initial and subsequent device modifications, regulatory compliance management, and administrative tasks. Operations focus on streamlining these areas for manufacturers in the healthcare sector.
Essenvia's top competitors include RIMSYS, Sware and ValGenesis.
Essenvia offers eSTAR Interface, RIM Platform, Registrations Management, Submissions Management, and Change Assessment.
Essenvia has 6 investors. Key investors include Benhamou Global Ventures, Pasadena Angels, Wavemaker 360, First Rays Venture Partners, and Rebright Partners.